Literature DB >> 17291534

Effect of 6-gingerol on pro-inflammatory cytokine production and costimulatory molecule expression in murine peritoneal macrophages.

Sudipta Tripathi1, Kristopher G Maier, David Bruch, Dilip S Kittur.   

Abstract

BACKGROUND: Pro-inflammatory cytokines produced primarily by macrophages are key elements in many surgical conditions including sepsis, ischemia-reperfusion injury, and transplant rejection. Herbal products are being used as alternative treatments in such inflammatory conditions. Ginger is known for its ethno-botanical applications as an anti-inflammatory agent. 6-gingerol is one of the active ingredients of ginger that imparts ginger with its anti-inflammatory properties. We hypothesized that the anti-inflammatory effect of 6-gingerol is because of inhibition of macrophage activation, more specifically by an inhibition of pro-inflammatory cytokines and antigen presentation by lipopolysaccharide (LPS) activated macrophages.
METHODS: To study the effect of 6-gingerol on pro-inflammatory cytokines, we measured the liberation of TNF-alpha, IL-1beta, and IL-12 by murine peritoneal macrophages exposed to several doses of 6-gingerol in the presence of LPS stimulation. We also studied the effect of 6-gingerol on the cell surface expression of B7.1, B7.2, and MHC II. Finally, we examined the APC function of the 6-gingerol treated macrophages by a primary mixed lymphocyte reaction.
RESULTS: 6-gingerol inhibited the production of pro-inflammatory cytokines from LPS stimulated macrophages but had no effect on the LPS-induced expression of B7.1, B7.2, and MHC II. The APC function of LPS stimulated macrophages was also unaffected by 6-gingerol treatment.
CONCLUSION: Our data indicate that 6-gingerol selectively inhibits production of pro-inflammatory cytokines from macrophages but does not affect either the APC function or cell surface expression of MHC II and costimulatory molecules. We, thus, provide a mechanistic insight into the anti-inflammatory properties of 6-gingerol that may be useful to treat inflammation without interfering with the antigen presenting function of macrophages.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17291534     DOI: 10.1016/j.jss.2006.07.051

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  27 in total

1.  Gingerol fraction from Zingiber officinale protects against gentamicin-induced nephrotoxicity.

Authors:  Francisco A P Rodrigues; Mara M G Prata; Iris C M Oliveira; Natacha T Q Alves; Rosa E M Freitas; Helena S A Monteiro; Jame's A Silva; Paulo C Vieira; Daniel A Viana; Alexandre B Libório; Alexandre Havt
Journal:  Antimicrob Agents Chemother       Date:  2014-01-06       Impact factor: 5.191

Review 2.  Age-associated chronic diseases require age-old medicine: role of chronic inflammation.

Authors:  Sahdeo Prasad; Bokyung Sung; Bharat B Aggarwal
Journal:  Prev Med       Date:  2011-12-09       Impact factor: 4.018

Review 3.  Molecular targets of nutraceuticals derived from dietary spices: potential role in suppression of inflammation and tumorigenesis.

Authors:  Bharat B Aggarwal; Michelle E Van Kuiken; Laxmi H Iyer; Kuzhuvelil B Harikumar; Bokyung Sung
Journal:  Exp Biol Med (Maywood)       Date:  2009-06-02

4.  Gingerol protects against experimental liver fibrosis in rats via suppression of pro-inflammatory and profibrogenic mediators.

Authors:  Mardi M Algandaby; Ali M El-Halawany; Hossam M Abdallah; Abdulrahman M Alahdal; Ayman A Nagy; Osama M Ashour; Ashraf B Abdel-Naim
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-01-26       Impact factor: 3.000

5.  Ginger and its bioactive component 6-shogaol mitigate lung inflammation in a murine asthma model.

Authors:  Gene T Yocum; Julie J Hwang; Maya Mikami; Jennifer Danielsson; Aisha S Kuforiji; Charles W Emala
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-12-04       Impact factor: 5.464

6.  Simultaneous use of traditional Chinese medicine (si-ni-tang) to treat septic shock patients: study protocol for a randomized controlled trial.

Authors:  Huang-Chi Chen; Wen-Chi Chen; Kai-Huang Lin; Yung-Hsiang Chen; Lun-Chien Lo; Tsung-Chieh Lee; Te-Chun Hsia; Chu-Hsien Wang; Shin-Hwar Wu; Hsin-Whae Hsu; Yu-Jun Chang; Yu-Chuen Huang; Tien-Hsiung Ku; Ming-Hwarng Horng
Journal:  Trials       Date:  2011-08-24       Impact factor: 2.279

7.  Analysis of Effectiveness of a Supplement Combining Harpagophytum procumbens, Zingiber officinale and Bixa orellana in Healthy Recreational Runners with Self-Reported Knee Pain: A Pilot, Randomized, Triple-Blind, Placebo-Controlled Trial.

Authors:  Marcela González-Gross; Carlos Quesada-González; Javier Rueda; Manuel Sillero-Quintana; Nicolas Issaly; Angel Enrique Díaz; Eva Gesteiro; David Escobar-Toledo; Rafael Torres-Peralta; Marc Roller; Amelia Guadalupe-Grau
Journal:  Int J Environ Res Public Health       Date:  2021-05-22       Impact factor: 3.390

8.  Attenuation of Proinflammatory Responses by S-[6]-Gingerol via Inhibition of ROS/NF-Kappa B/COX2 Activation in HuH7 Cells.

Authors:  Xiao-Hong Li; Kristine C Y McGrath; Van H Tran; Yi-Ming Li; Colin C Duke; Basil D Roufogalis; Alison K Heather
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-16       Impact factor: 2.629

9.  Improvement of liquid fructose-induced adipose tissue insulin resistance by ginger treatment in rats is associated with suppression of adipose macrophage-related proinflammatory cytokines.

Authors:  Jianwei Wang; Huanqing Gao; Dazhi Ke; Guowei Zuo; Yifan Yang; Johji Yamahara; Yuhao Li
Journal:  Evid Based Complement Alternat Med       Date:  2013-02-21       Impact factor: 2.629

10.  Bees' honey attenuation of metanil-yellow-induced hepatotoxicity in rats.

Authors:  Abdulrahman L Al-Malki; Ahmed Amir Radwan Sayed
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-03       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.